NO171851C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt 6-cyano-4-(1,2-dihydro-2-okso-pyrid-1-yl)-2,2-dimetylkromen - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktivt 6-cyano-4-(1,2-dihydro-2-okso-pyrid-1-yl)-2,2-dimetylkromenInfo
- Publication number
- NO171851C NO171851C NO884533A NO884533A NO171851C NO 171851 C NO171851 C NO 171851C NO 884533 A NO884533 A NO 884533A NO 884533 A NO884533 A NO 884533A NO 171851 C NO171851 C NO 171851C
- Authority
- NO
- Norway
- Prior art keywords
- pyrid
- chrome
- dihydro
- oxo
- cyano
- Prior art date
Links
- -1 1,2-DIHYDRO-2-OXO-PYRID-1-YL Chemical class 0.000 title 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8714067A FR2621587B1 (fr) | 1987-10-12 | 1987-10-12 | Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO884533D0 NO884533D0 (no) | 1988-10-11 |
| NO884533L NO884533L (no) | 1989-04-13 |
| NO171851B NO171851B (no) | 1993-02-01 |
| NO171851C true NO171851C (no) | 1993-05-12 |
Family
ID=9355735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO884533A NO171851C (no) | 1987-10-12 | 1988-10-11 | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 6-cyano-4-(1,2-dihydro-2-okso-pyrid-1-yl)-2,2-dimetylkromen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5391751A (xx) |
| EP (2) | EP0556872A1 (xx) |
| JP (1) | JPH02180A (xx) |
| KR (1) | KR890006625A (xx) |
| AR (1) | AR246521A1 (xx) |
| AT (1) | ATE100095T1 (xx) |
| AU (1) | AU619766B2 (xx) |
| CA (1) | CA1329603C (xx) |
| DE (1) | DE3887068D1 (xx) |
| DK (1) | DK567188A (xx) |
| FI (1) | FI90545C (xx) |
| FR (1) | FR2621587B1 (xx) |
| IE (1) | IE940342L (xx) |
| IL (1) | IL88002A (xx) |
| NO (1) | NO171851C (xx) |
| NZ (1) | NZ226516A (xx) |
| PT (1) | PT88718B (xx) |
| ZA (1) | ZA887607B (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3726261A1 (de) * | 1986-12-23 | 1988-07-07 | Merck Patent Gmbh | Chromanderivate |
| US5387587A (en) * | 1986-12-23 | 1995-02-07 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Chroman derivatives |
| US5284838A (en) * | 1987-06-23 | 1994-02-08 | Elf Sanofi | Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma |
| EP0373204A1 (en) * | 1988-05-09 | 1990-06-20 | Beecham Group Plc | Novel compounds and treatment |
| EP0346724A1 (de) * | 1988-06-16 | 1989-12-20 | MERCK PATENT GmbH | Chromanderivate |
| ES2071668T3 (es) * | 1988-12-13 | 1995-07-01 | Beecham Group Plc | Benzopirano y compuestos relacionados. |
| DE3923839A1 (de) * | 1989-07-19 | 1991-01-31 | Beiersdorf Ag | Benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen |
| DE3924417A1 (de) * | 1989-07-24 | 1991-01-31 | Merck Patent Gmbh | Chromanderivate |
| FR2657872B2 (fr) * | 1989-11-06 | 1992-06-12 | Sanofi Sa | Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant. |
| FR2654103B1 (fr) * | 1989-11-06 | 1992-02-21 | Sanofi Sa | Derives d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques les contenant. |
| US5185345A (en) * | 1989-11-06 | 1993-02-09 | Sanofi | 4-amidino pyrano (3,2-c) pyridine derivatives, and pharmaceutical compositions containing them |
| US5177616A (en) * | 1991-12-02 | 1993-01-05 | Matsushita Avionics Systems | Stowable video display assembly |
| DE102004005179B4 (de) * | 2004-02-02 | 2006-07-13 | Wobben, Aloys, Dipl.-Ing. | Windenergieanlage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE23718T1 (de) * | 1981-09-25 | 1986-12-15 | Beecham Group Plc | Benzopyran-verbindungen mit pharmazeutischer wirkung. |
| GB8521857D0 (en) * | 1985-09-03 | 1985-10-09 | Beecham Group Plc | Active compounds |
| DE3726261A1 (de) * | 1986-12-23 | 1988-07-07 | Merck Patent Gmbh | Chromanderivate |
| EP0346724A1 (de) * | 1988-06-16 | 1989-12-20 | MERCK PATENT GmbH | Chromanderivate |
| ES2071668T3 (es) * | 1988-12-13 | 1995-07-01 | Beecham Group Plc | Benzopirano y compuestos relacionados. |
-
1987
- 1987-10-12 FR FR8714067A patent/FR2621587B1/fr not_active Expired - Fee Related
-
1988
- 1988-10-07 IE IE940342A patent/IE940342L/xx unknown
- 1988-10-10 EP EP93106947A patent/EP0556872A1/fr not_active Ceased
- 1988-10-10 DE DE88402548T patent/DE3887068D1/de not_active Expired - Lifetime
- 1988-10-10 AT AT88402548T patent/ATE100095T1/de not_active IP Right Cessation
- 1988-10-10 PT PT88718A patent/PT88718B/pt not_active IP Right Cessation
- 1988-10-10 NZ NZ226516A patent/NZ226516A/xx unknown
- 1988-10-10 EP EP88402548A patent/EP0312432B1/fr not_active Expired - Lifetime
- 1988-10-11 IL IL8800288A patent/IL88002A/en not_active IP Right Cessation
- 1988-10-11 AR AR88312155A patent/AR246521A1/es active
- 1988-10-11 NO NO884533A patent/NO171851C/no unknown
- 1988-10-11 CA CA000579795A patent/CA1329603C/en not_active Expired - Fee Related
- 1988-10-11 DK DK567188A patent/DK567188A/da not_active Application Discontinuation
- 1988-10-11 FI FI884660A patent/FI90545C/fi not_active IP Right Cessation
- 1988-10-12 AU AU23660/88A patent/AU619766B2/en not_active Ceased
- 1988-10-12 ZA ZA887607A patent/ZA887607B/xx unknown
- 1988-10-12 KR KR1019880013314A patent/KR890006625A/ko not_active Application Discontinuation
- 1988-10-12 JP JP63255046A patent/JPH02180A/ja active Pending
-
1991
- 1991-08-19 US US07/746,974 patent/US5391751A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO884533D0 (no) | 1988-10-11 |
| AU2366088A (en) | 1989-04-13 |
| DK567188A (da) | 1989-04-13 |
| DK567188D0 (da) | 1988-10-11 |
| EP0556872A1 (fr) | 1993-08-25 |
| NO171851B (no) | 1993-02-01 |
| EP0312432B1 (fr) | 1994-01-12 |
| ATE100095T1 (de) | 1994-01-15 |
| FI90545B (fi) | 1993-11-15 |
| JPH02180A (ja) | 1990-01-05 |
| KR890006625A (ko) | 1989-06-14 |
| FR2621587B1 (fr) | 1990-02-09 |
| AR246521A1 (es) | 1994-08-31 |
| FR2621587A1 (fr) | 1989-04-14 |
| IL88002A0 (en) | 1989-06-30 |
| DE3887068D1 (de) | 1994-02-24 |
| IE940342L (en) | 1989-04-12 |
| NO884533L (no) | 1989-04-13 |
| US5391751A (en) | 1995-02-21 |
| EP0312432A1 (fr) | 1989-04-19 |
| FI90545C (fi) | 1994-02-25 |
| CA1329603C (en) | 1994-05-17 |
| ZA887607B (en) | 1989-06-28 |
| FI884660A0 (fi) | 1988-10-11 |
| FI884660A (fi) | 1989-04-13 |
| NZ226516A (en) | 1990-05-28 |
| IL88002A (en) | 1994-08-26 |
| PT88718B (pt) | 1992-12-31 |
| AU619766B2 (en) | 1992-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO895086L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
| NO903088L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
| NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
| NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
| NO171851C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 6-cyano-4-(1,2-dihydro-2-okso-pyrid-1-yl)-2,2-dimetylkromen | |
| NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO171909C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO171857C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater | |
| NO172490C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater | |
| NO171847C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater | |
| NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
| NO168040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
| NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
| NO900972L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO893768L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater. | |
| NO170282C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO167511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater. |